miR-125b通过VEGFA介导的非细胞内在机制促进MLL-AF9驱动的小鼠急性髓系白血病
研究通过可多西环素诱导miR-125b过表达的基因敲入小鼠模型,发现miR-125b显著增强MLL-AF9驱动的急性髓系白血病,且白血病部分依赖miR-125b持续过表达。miR-125b通过抑制TET2上调白血病细胞VEGFA表达,重组VEGFA可重现其促白血病效应,而敲低VEGFA或抑制VEGFR2可消除该效应。
要点
- miR-125b与MLL-AF9协同增强小鼠急性髓系白血病,白血病部分依赖miR-125b持续过表达
- miR-125b以非细胞内在机制促进白血病细胞扩增并抑制凋亡
- miR-125b通过抑制TET2上调VEGFA,VEGFA/VEGFR2通路介导其促白血病效应
核心结论
- miR-125b与MLL癌基因在急性髓系白血病发生中具有协同和依赖关系,并通过miR-125b-TET2-VEGFA通路介导非细胞内在的促白血病效应。
研究设计与样本
- 研究构建了多西环素诱导控制miR-125b过表达的基因敲入小鼠模型,用以分析miR-125b与MLL-AF9的功能协同。
主要发现
- miR-125b显著增强MLL-AF9驱动的小鼠急性髓系白血病,所得白血病部分依赖miR-125b持续过表达。
- miR-125b以非细胞内在机制促进白血病细胞扩增并抑制凋亡。
- miR-125b部分通过抑制TET2增强白血病细胞VEGFA表达和产生。
- 重组VEGFA可重现miR-125b的促白血病效应,而敲低VEGFA或抑制VEGF受体2可消除miR-125b的效应。
- 在人类急性髓系白血病中观察到miR-125b与VEGFA表达显著相关。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The hematopoietic stem cell-enriched miR-125 family microRNAs (miRNAs) are critical regulators of hematopoiesis. Overexpression of miR-125a or miR-125b is frequent in human acute myeloid leukemia (AML), and the overexpression of these miRNAs in mice leads to expansion of hematopoietic stem cells accompanied by perturbed hematopoiesis with mostly myeloproliferative phenotypes. However, whether and how miR-125 family miRNAs cooperate with known AML oncogenes in vivo, and how the resultant leukemia is dependent on miR-125 overexpression, are not well understood. We modeled the frequent co-occurrence of miR-125b overexpression and MLL translocations by examining functional cooperation between miR-125b and MLL-AF9 By generating a knock-in mouse model in which miR-125b overexpression is controlled by doxycycline induction, we demonstrated that miR-125b significantly enhances MLL-AF9-driven AML in vivo, and the resultant leukemia is partially dependent on continued overexpression of miR-125b Surprisingly, miR-125b promotes AML cell expansion and suppresses apoptosis involving a non-cell-intrinsic mechanism. MiR-125b expression enhances VEGFA expression and production from leukemia cells, in part by suppressing TET2 Recombinant VEGFA recapitulates the leukemia-promoting effects of miR-125b, whereas knockdown of VEGFA or inhibition of VEGF receptor 2 abolishes the effects of miR-125b In addition, significant correlation between miR-125b and VEGFA expression is observed in human AMLs. Our data reveal cooperative and dependent relationships between miR-125b and the MLL oncogene in AML leukemogenesis, and demonstrate a miR-125b-TET2-VEGFA pathway in mediating non-cell-intrinsic leukemia-promoting effects by an oncogenic miRNA.
引用
- Liu J, Guo B, Chen Z, et al. miR-125b promotes MLL-AF9-driven murine acute myeloid leukemia involving a VEGFA-mediated non-cell-intrinsic mechanism. Blood. 2017. PMID: 28053194. doi:10.1182/blood-2016-06-721027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。